Keyphrases
Type 2 Diabetes Mellitus (T2DM)
100%
Functional Response
100%
Metabolic Response
100%
Diabetic Therapy
100%
Metformin
80%
Fatty Acids
40%
Diastolic Function
40%
Fatty Acid Composition
40%
Myocardial Metabolism
40%
Fatty Acid Utilization
40%
Myocardial Substrate Metabolism
40%
Rosiglitazone
40%
Plasma Fatty Acids
40%
Myocardial Fat
40%
Lipid Delivery
40%
Lovaza
40%
Whole-body
20%
Lipid Metabolism
20%
Triglycerides
20%
Positron Emission Tomography
20%
Diastolic Dysfunction
20%
Echocardiography
20%
Triglyceride Level
20%
Fatty Acid Oxidation
20%
Glucose Utilization
20%
Diabetes Management
20%
Sex-specific
20%
Tracer Study
20%
Human Heart
20%
Metabolism Function
20%
Therapeutic Regimen
20%
Myocardial Glucose Uptake
20%
Lipid-lowering
20%
T2DM Patients
20%
Lipid Fatty Acid
20%
Biochemistry, Genetics and Molecular Biology
Lipid
100%
Metabolic Pathway
75%
Fatty Acid Blood Level
50%
Fatty Acid Level
50%
Heart Muscle Metabolism
50%
Rosiglitazone
50%
Lipid Metabolism
25%
Triglyceride
25%
Animal Model
25%
Glucose Transport
25%
Triacylglycerol Level
25%
Positron Emission Tomography
25%
Glucose Utilization
25%
Medicine and Dentistry
Fatty Acid
100%
Type 2 Diabetes
85%
Glycon
42%
Triacylglycerol
28%
Diastolic Function
28%
Heart Muscle Metabolism
28%
Omega 3 Acid Ethyl Ester
28%
Positron Emission Tomography
14%
Diabetes
14%
Maturity Onset Diabetes of the Young
14%
Echocardiography
14%
Radioactive Tracer
14%
Glucose Uptake
14%
Glucose Utilization
14%
Metabolism
14%
Lipid Metabolism
14%
Rosiglitazone
14%
Metformin Plus Rosiglitazone
14%
Diastolic Dysfunction
14%
Pharmacology, Toxicology and Pharmaceutical Science
Fatty Acid
100%
Metformin
42%
Triacylglycerol
28%
Omega 3 Acid Ethyl Ester
28%
Tracer
14%
Rosiglitazone
14%
Metformin Plus Rosiglitazone
14%
Diastolic Dysfunction
14%
Non Insulin Dependent Diabetes Mellitus
14%